Clinical Trial Update: Thalidomide in Treating Patients With Relapsed or Progressive Systemic Mastocytosis

View source ↗

Summary

A completed clinical trial studied thalidomide for relapsed or progressive systemic mastocytosis. The update does not provide trial results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Systemic Mastocytosis

Drugs mentioned

• Thalidomide (thalidomide)

Snippet

Sponsor: Centre Hospitalier Universitaire, Amiens | Conditions: Non Neoplastic Condition, Precancerous Condition | Status: COMPLETED